clear space clear space clear space white space
A
 r c h i v e s   o f   M a r y l a n d   O n l i n e
  Maryland State Archives | Index | Help | Search search for:
clear space
white space
Session Laws, 2000
Volume 797, Page 753   View pdf image
 Jump to  
  << PREVIOUS  NEXT >>
clear space clear space clear space white space
Ch. 123
PARRIS N. GLENDENING, Governor
(4) flexible enough to allow deviations from norms when justified on a
case by case basis.] A PRIVATE REVIEW AGENT SHALL ADVISE THE COMMISSIONER, IN WRITING, OF
A CHANGE IN: (1) CORPORATE OWNERSHIP, MEDICAL DIRECTOR OR CHIEF EXECUTIVE
OFFICER AT LEAST 60 DAYS BEFORE WITHIN 30 DAYS OF THE DATE OF THE CHANGE; (2) THE NAME, ADDRESS, OR TELEPHONE NUMBER OF THE PRIVATE
REVIEW AGENT WITHIN 30 DAYS OF THE DATE OF THE CHANGE; OR (3) THE PRIVATE REVIEW AGENT'S SCOPE OF RESPONSIBILITY UNDER A
CONTRACT. 15-10B-06. [(a) In this section, "utilization review" means a system for reviewing the
appropriate and efficient allocation of health care resources and services given or
proposed to be given to a patient or group of patients by a health care provider,
including a hospital or an intermediate care facility described under § 8-403(e) of the
Health - General Article. (b) In addition to any other requirements under this subtitle, a private review
agent performing utilization review of services related to the treatment of alcoholism,
drug abuse, or mental illness shall meet the requirements of this section. (c) All adverse decisions shall be made by a physician, or a panel of other
appropriate health care providers with at least 1 physician, selected by the private
review agent who is: (1) (i) board certified or eligible in the same specialty as the treatment
under review; or (ii) actively practicing, or has demonstrated expertise, in the
alcohol, drug abuse, or mental health service or treatment under review; and (2) not compensated by the private review agent in a manner that
provides a financial incentive directly or indirectly to deny or reduce coverage. (d) If a course of treatment has been preauthorized or approved for a patient,
a private review agent may not revise or modify the specific criteria or standards used
for the utilization review to make an adverse decision regarding the services delivered
to that patient. (e) (1) In the event a patient or health care provider, including a physician,
intermediate care facility described under § 8-403(e) of the Health - General Article,
or hospital seeks reconsideration or appeal of an adverse decision by a private review
agent, the final determination of the appeal of the adverse decision shall be made
based on the professional judgment of a physician, or a panel of other appropriate
health care providers with at least 1 physician, selected by the private review agent
who is:
- 753 -


 
clear space
clear space
white space

Please view image to verify text. To report an error, please contact us.
Session Laws, 2000
Volume 797, Page 753   View pdf image
 Jump to  
  << PREVIOUS  NEXT >>


This web site is presented for reference purposes under the doctrine of fair use. When this material is used, in whole or in part, proper citation and credit must be attributed to the Maryland State Archives. PLEASE NOTE: The site may contain material from other sources which may be under copyright. Rights assessment, and full originating source citation, is the responsibility of the user.


Tell Us What You Think About the Maryland State Archives Website!



An Archives of Maryland electronic publication.
For information contact msa.helpdesk@maryland.gov.

©Copyright  August 17, 2024
Maryland State Archives